Table 2.
Characteristics of patients with positive FDG-PET/CT findings.
| Patient number | Gender/age | Previous history of cancer (age) | Concentration area | TP53 mutation | SUV max | Histopathological or imaging diagnosis |
|---|---|---|---|---|---|---|
| 04 | F/67 | Breast (51, 61); thyroid (62); skin (65) | Lung | p.R337H | 1.7 | Mixed acinar/bronchiolo-alveolar carcinoma |
| 11 | F/62 | No | Pelvis | p.T125T | 5.1 | Adenocarcinoma of the ovary |
| 07 | F/40 | Breast (38) | Bones/liver | p.R337H | 5.8 | Metastases of breast cancer |
| 01 | F/29 | No | Pelvis | p.R337H | 2.02 | Bartholin cyst |
| 16 | F/60 | No | Mesenteric root | p.T125T | 7.0 | Lymph nodes; reactive hyperplasia |
| 20 | M/56 | Thyroid (54) | Right axillary | p.R337H | 2.0 | Single lymph node; reactive hyperplasia |
F, female; M, male.